financetom
Business
financetom
/
Business
/
Black Stone Minerals appoints Fowler Carter and Taylor DeWalch as co-CEOs, Q3 net income falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Black Stone Minerals appoints Fowler Carter and Taylor DeWalch as co-CEOs, Q3 net income falls
Nov 3, 2025 2:55 PM

Overview

* Black Stone Q3 adjusted EBITDA beats estimates, reflecting operational efficiency

* Oil and gas revenue for Q3 decreased 2% from the previous quarter

* Company announces leadership succession plan effective January 2026, appoints Fowler Carter and Taylor DeWalch as co-CEOs

Outlook

* Company did not provide specific financial guidance for the current quarter or full year in the statement

Result Drivers

* PRODUCTION INCREASE - Mineral and royalty production rose 5% in Q3 compared to the prior quarter

* DEVELOPMENT ACTIVITY - Aethon Energy's development program on track with wells turned to sales and more expected in 2025

* ACQUISITION STRATEGY - Acquired $20.3 mln of mineral and royalty interests in Q3, focusing on Shelby Trough area

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Oil & $100.20

Gas mln

Revenue

Q3 Net $91.70

Income mln

Q3 Beat $86.30 $81.80

Adjusted mln mln (4

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas exploration and production peer group is "buy."

* Wall Street's median 12-month price target for Black Stone Minerals LP ( BSM ) is $15.00, about 12.7% above its November 3 closing price of $13.10

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hewlett Packard Enterprise's HPE Asset Upcycling Services Selected by Astellas Pharma
Hewlett Packard Enterprise's HPE Asset Upcycling Services Selected by Astellas Pharma
Mar 14, 2024
10:41 AM EDT, 03/14/2024 (MT Newswires) -- Hewlett Packard Enterprise ( HPE ) said Thursday that Astellas Pharma has picked HPE Asset Upcycling Services to support its sustainability goals. Technology assets, such as networking equipment, servers, computers, and smartphones, will be decommissioned for safe refurbishment, the company said. Every year, Astellas will receive an HPE Circular Economy report, showing how...
Zara owner Inditex flags one-week delays due to Red Sea crisis
Zara owner Inditex flags one-week delays due to Red Sea crisis
Mar 14, 2024
MADRID (Reuters) - The world's biggest apparel retailer Inditex said average shipping times have been delayed by about a week by the Red Sea crisis, as container ships carrying its products avoid the Suez Canal and travel around the southern tip of Africa. Yemen's Houthis have kept up a relentless campaign of attacks on vessels in one of the world's...
Enfusion Shares Slip After Short-Seller Spruce Point Warns of 'Financial Restatement Risk'
Enfusion Shares Slip After Short-Seller Spruce Point Warns of 'Financial Restatement Risk'
Mar 14, 2024
10:37 AM EDT, 03/14/2024 (MT Newswires) -- Enfusion ( ENFN ) shares slipped 2.5% in recent Thursday trading after short-seller Spruce Point Management raised concerns about the company's financial restatement risk. Enfusion ( ENFN ) did not immediately respond to a request for comment by MT Newswires. We believe revenue is at high risk of misstatement as we find accounts...
Tilray Brands Gets Approval for First Medical Cannabis Extract in Portugal
Tilray Brands Gets Approval for First Medical Cannabis Extract in Portugal
Mar 14, 2024
10:40 AM EDT, 03/14/2024 (MT Newswires) -- Tilray Brands ( TLRY ) said Thursday Tilray Medical has received approval for its first medical cannabis extract in Portugal. The newly approved Tilray Oral Solution THC 5 CBD 20 extract is scheduled to be launched in late spring and will provide new therapeutic options for patients with specified medical conditions, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved